Sensorion SA - Asset Resilience Ratio

Latest as of December 2025: 92.55%

Sensorion SA (ALSEN) has an Asset Resilience Ratio of 92.55% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ALSEN working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€53.57 Million

≈ $62.63 Million USD Cash + Short-term Investments

Total Assets

€57.89 Million

≈ $67.68 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Sensorion SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Sensorion SA assets under control.

Liquid Assets Composition Over Time

This chart breaks down Sensorion SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ALSEN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€26.79 Million	46.27%
Short-term Investments	€26.79 Million	46.27%
Total Liquid Assets	€53.57 Million	92.55%

Asset Resilience Insights

Very High Liquidity: Sensorion SA maintains exceptional liquid asset reserves at 92.55% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company maintains a balanced mix of cash and short-term investments.

Sensorion SA Industry Peers by Asset Resilience Ratio

Compare Sensorion SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Sensorion SA (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Sensorion SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	92.55%	€53.57 Million ≈ $62.63 Million	€57.89 Million ≈ $67.68 Million	+22.91pp
2024-12-31	69.64%	€62.18 Million ≈ $72.69 Million	€89.28 Million ≈ $104.37 Million	+34.24pp
2020-12-31	35.41%	€24.03 Million ≈ $28.09 Million	€67.87 Million ≈ $79.35 Million	+9.15pp
2019-12-31	26.25%	€10.00 Million ≈ $11.69 Million	€38.09 Million ≈ $44.53 Million	+26.08pp
2018-12-31	0.17%	€16.00K ≈ $18.71K	€9.47 Million ≈ $11.07 Million	-85.87pp
2017-12-31	86.04%	€9.60 Million ≈ $11.23 Million	€11.16 Million ≈ $13.05 Million	+14.10pp
2016-12-31	71.94%	€8.53 Million ≈ $9.97 Million	€11.85 Million ≈ $13.86 Million	--

pp = percentage points

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$5.53 Billion

€4.73 Billion EUR

Market Cap Rank

#18527 Global

#268 in France

Share Price

€9.19

Change (1 day)

-2.29%

52-Week Range

€0.22 - €10.47

All Time High

€12.53